Abstract
The clinical effects of discordance in receptor status between primary and metastatic breast cancer lesions are discussed in relation to the study of Macfarlane et al. published in this issue of The Oncologist.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
